Table 2.
Demographic data on respondents.
| Total (n=15) | Round 1 (n=7) | Round 2 (n=8) | |
|---|---|---|---|
| Age, Mean (SD) | 61 (8.6) | 62 (4.7) | 60 (11.3) |
| Sex, n (%) | |||
| Male | 11 (73.3%) | 6 (85.7%) | 5 (62.5%) |
| Female | 4 (26.7%) | 1 (14.3%) | 3 (37.5%) |
| Ethnicity, n (%) | |||
| Hispanic | 0 (0%) | 0 (0%) | 0 (0%) |
| Non-Hispanic | 15 (100%) | 7 (100%) | 8 (100%) |
| Race, n (%) | |||
| Black | 8 (53.3%) | 4 (57.1%) | 4 (50.0%) |
| White | 6 (40.0%) | 3 (42.9%) | 3 (37.5%) |
| Mixed Race | 1 (6.7%) | 0 (0%) | 1 (12.5%) |
| Marital Status, n (%) | |||
| Married | 7 (46.7%) | 5 (71.4%) | 2 (25.0%) |
| Not Married | 8 (53.3%) | 2 (28.6%) | 6 (75.0%) |
| Education, n (%) | |||
| Less than high school | 1 (6.7%) | 0 (0%) | 1 (12.5%) |
| Highschool graduate/GED | 2 (13.3%) | 1 (14.3%) | 1 (12.5%) |
| Some college | 9 (60.0%) | 5 (71.4%) | 4 (50.0%) |
| College grad or higher | 3 (20.0%) | 1 (14.3%) | 2 (25.5%) |
| Employment, n (%) | |||
| Employed | 5 (33.3%) | 1 (14.3%) | 4 (50.0%) |
| Not employed | 10 (66.7%) | 7 (87.5%) | 4 (50.0%) |
| Medications, n (%) | |||
| Insulin | 10 (66.7%) | 5 (71.4%) | 5 (62.5%) |
| Non-insulin | 5 (33.3%) | 2 (28.6%) | 3 (37.5%) |
| Income, n (%) | |||
| Less than $30,000 | 9 (60.0%) | 5 (71.4%) | 4 (50.0%) |
| $30,000 to $59,999 | 3 (20.0%) | 1 (14.3%) | 2 (25.0%) |
| More than $60,000 | 3 (20.0%) | 1 (14.3%) | 2 (25.0%) |
| Self-rated quality of health, n (%) | |||
| Fair, poor | 4 (26.7%) | 3 (42.9%) | 1 (12.5%) |
| Good, very good, excellent | 11 (73.3%) | 4 (57.1%) | 7 (87.5%) |
| Impact of coronavirus on answers, n (%) | |||
| Moderate or greater extent | 5 (33.3%) | 3 (42.9%) | 2 (25.0%) |
| None to small extent | 10 (66.7%) | 4 (57.1%) | 6 (75.0%) |
| Comorbidities, n (%) | |||
| Hypertension | 15 (100%) | 7 (100%) | 8 (100%) |
| High cholesterol | 15 (100%) | 7 (100%) | 8 (100%) |
| Posttraumatic Stress Disorder | 2 (13.3%) | 1 (14.3%) | 1 (12.5%) |
| Depression | 6 (40.0%) | 3 (42.9%) | 3 (37.5%) |
| Anxiety | 1 (6.7%) | 0 (0%) | 1 (12.5%) |
| Glycosylated hemoglobin, n (%) | |||
| < 9% | 8 (53.3%) | 5 (71.4%) | 3 (37.5%) |
| ≥ 9% | 7 (46.7%) | 2 (28.6%) | 5 (62.5%) |
| Frequency of alcohol intake, n (%) | |||
| 4 or more times per week | 1 (6.7%) | 0 (0%) | 1 (12.5%) |
| 2–3 times per week | 1 (6.7%) | 0 (0%) | 1 (12.5%) |
| 2–4 times per month | 3 (20.0%) | 2 (28.6%) | 1 (12.5%) |
| Monthly or less | 5 (33.3%) | 3 (42.9%) | 2 (25.0%) |
| Never | 5 (33.3%) | 2 (28.6%) | 3 (37.5%) |
| Visit to a non-VHA health care provider in past year, n (%) | |||
| Yes | 5 (33.3%) | 2 (28.6%) | 3 (37.5%) |
| No | 10 (66.7%) | 5 (71.4%) | 5 (62.5%) |
| Non-VHA insurance or program that helps pay for your prescription medications, n (%) | |||
| Yes | 3 (20.0%) | 1 (14.3%) | 2 (25.0%) |
| No | 12 (80.0%) | 6 (85.7%) | 6 (75.0%) |
Note: VHA, Veterans Health Affairs